{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:13:19Z","timestamp":1793373199825,"version":"4.5.0"},"reference-count":52,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2026,3,3]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Individual breast cancer risk can guide screening initiation, frequency, use of supplemental imaging, and preventive measures to improve breast cancer screening by shifting resources from low-risk women to high-risk women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether risk-based breast cancer screening is a feasible alternative to annual mammography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Parallel-group, pragmatic, multicenter randomized clinical trial comparing risk-based (n\u2009=\u200914\u202f212) with annual (n\u2009=\u200914\u202f160) breast cancer screening. Women aged 40 to 74 years without prior diagnoses of breast cancer or ductal carcinoma in situ, or prophylactic bilateral mastectomy, were recruited from all 50 US states from September 2016 to February 2023, with follow-up through September 5, 2025 (median follow-up, 5.1 years). Statistical analysis was conducted between July and November 2025. All study procedures were conducted via an online platform. Women who declined randomization were enrolled in an observational cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Risk assessment included sequencing of 9 susceptibility genes, polygenic risk score, and the Breast Cancer Surveillance Consortium version 2 model. The risk-based group received 1 of 4 recommendations: (1) highest risk (\u22656% 5-year risk, high-penetrance pathogenic variant): alternating mammography and magnetic resonance imaging (MRI) every 6 months and counseling; (2) elevated risk (top 2.5 risk percentile by age): annual mammography and risk-reduction counseling; (3) average risk: biennial mammography; and (4) low risk (aged 40-49 years and &amp;amp;lt;1.3% 5-year risk): no screening until risk is 1.3% or greater or age 50 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The coprimary outcomes included noninferiority for stage \u2265IIB cancers and superiority in reducing biopsy rates. Secondary outcomes included identification of stage \u2265IIA cancers, mammogram rates, uptake of prevention strategies in higher risk cohorts, preference for screening group in the observational cohort, ductal carcinoma in situ, MRI, and stage-specific cancer rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 28\u202f372 women were randomized. The mean (SD) age was 54 (9.6) years and the majority were non-Hispanic White (77%). The rate of stage \u2265IIB cancers was noninferior in the risk-based compared with the annual group (risk-based: 30.0 [95% CI, 16.3-43.8] vs annual: 48.0 [95% CI, 30.1-65.5] per 100\u202f000 person-years; rate difference, \u221218.0 per 100\u202f000 person-years [95% CI, \u221240.2 to 4.1]). The rate of breast biopsies was not lower in the risk-based group (rate difference, 98.7 per 100\u202f000 person-years [95% CI, \u221217.9 to 215.3]) despite fewer mammograms (rate difference, \u22123835.9 [95% CI, \u22124516.8 to \u22123154.9]). The cumulative incidence of cancer, biopsy, mammogram, and MRI increased as risk category increased. In the observational cohort, 89% of participants (15\u202f980\/18\u202f031) chose risk based.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Risk-based breast cancer screening that includes population-based genetic testing safely stratified risk and screening intensity, but did not reduce biopsy rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT02620852\">NCT02620852<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2025.24784","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T17:30:21Z","timestamp":1765560621000},"page":"763","source":"Crossref","is-referenced-by-count":62,"title":["Risk-Based vs Annual Breast Cancer Screening"],"prefix":"10.1001","volume":"335","author":[{"given":"Laura J.","family":"Esserman","sequence":"first","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison S.","family":"Fiscalini","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Naeim","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"van\u2018t Veer","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kaster","sequence":"additional","affiliation":[{"name":"Sanford Health, Fargo, North Dakota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren T.","family":"Scheuner","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"},{"name":"San Francisco VA Health Care System, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Z.","family":"LaCroix","sequence":"additional","affiliation":[{"name":"University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D.","family":"Borowsky","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Anton-Culver","sequence":"additional","affiliation":[{"name":"University of California, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufunmilayo I.","family":"Olopade","sequence":"additional","affiliation":[{"name":"University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Esserman","sequence":"additional","affiliation":[{"name":"Diagnostic Center of Miami, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Lancaster","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Madlensky","sequence":"additional","affiliation":[{"name":"University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie M.","family":"Blanco","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Ross","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Goodman","sequence":"additional","affiliation":[{"name":"University of California, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry S.","family":"Tong","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hogarth","sequence":"additional","affiliation":[{"name":"University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Heditsian","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Brain","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Lee","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Blum","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Ok","family":"Kim","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah P.","family":"Sabacan","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirkpatrick B.","family":"Fergus","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Yau","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Park","sequence":"additional","affiliation":[{"name":"University of California, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Parker","sequence":"additional","affiliation":[{"name":"University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Kaplan","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim F.","family":"Rhoads","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Eder","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Adduci","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Matthews","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil S.","family":"Wenger","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwey","family":"Shieh","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hiatt","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Ziv","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Tice","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eklund","sequence":"additional","affiliation":[{"name":"Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"joi250118r1","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1093\/jnci\/djae172","article-title":"Risk factors for breast cancer subtypes by race and ethnicity: a scoping review.","volume":"116","author":"Hurson","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"joi250118r2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10549-016-3953-2","article-title":"Breast cancer risk prediction using a clinical risk model and polygenic risk score.","volume":"159","author":"Shieh","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"joi250118r3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic risk scores for prediction of breast cancer and breast cancer subtypes.","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"2","key":"joi250118r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.56078","article-title":"Cost-effectiveness of population-based multigene testing for breast and ovarian cancer prevention.","volume":"7","author":"Guo","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"15","key":"joi250118r5","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1001\/jama.2009.1498","article-title":"Rethinking screening for breast cancer and prostate cancer.","volume":"302","author":"Esserman","year":"2009","journal-title":"JAMA"},{"issue":"12","key":"joi250118r6","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jama.1996.03530360023033","article-title":"Incidence of and treatment for ductal carcinoma in situ of the breast.","volume":"275","author":"Ernster","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"joi250118r7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1158\/1055-9965.EPI-14-1286","article-title":"The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.","volume":"24","author":"Gangnon","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"joi250118r8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3322\/caac.21321","article-title":"Cancer statistics: breast cancer in situ.","volume":"65","author":"Ward","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"10445","key":"joi250118r9","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1016\/S0140-6736(24)00425-2","article-title":"Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment.","volume":"403","author":"Delaloge","year":"2024","journal-title":"Lancet"},{"issue":"9","key":"joi250118r10","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1200\/JCO.2014.58.9986","article-title":"Risk factors and tumor characteristics of interval cancers by mammographic density.","volume":"33","author":"Holm","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"joi250118r11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10549-011-1670-4","article-title":"Locally advanced breast cancers are more likely to present as interval cancers: results from the I-SPY 1 TRIAL (CALGB 150007\/150012, ACRIN 6657, InterSPORE Trial).","volume":"132","author":"Lin","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"joi250118r12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7326\/0003-4819-155-8-201110180-00004","article-title":"Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.","volume":"155","author":"Hubbard","year":"2011","journal-title":"Ann Intern Med"},{"issue":"9","key":"joi250118r13","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/cncr.29199","article-title":"Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.","volume":"121","author":"Allison","year":"2015","journal-title":"Cancer"},{"issue":"2","key":"joi250118r15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-089428","article-title":"National yearly cost of breast cancer screening in the USA and projected cost of advocated guidelines: a simulation study with life table modelling.","volume":"15","author":"Badal","year":"2025","journal-title":"BMJ Open"},{"issue":"11","key":"joi250118r16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41571-020-0388-9","article-title":"Personalized early detection and prevention of breast cancer: ENVISION consensus statement.","volume":"17","author":"Pashayan","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"joi250118r17","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1001\/jamaoncol.2018.1901","article-title":"Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: a life-table model.","volume":"4","author":"Pashayan","year":"2018","journal-title":"JAMA Oncol"},{"issue":"2","key":"joi250118r18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1148\/radiol.2019181651","article-title":"Age-based versus risk-based mammography screening in women 40-49 years old: a cross-sectional study.","volume":"292","author":"Burnside","year":"2019","journal-title":"Radiology"},{"issue":"7","key":"joi250118r20","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.23.00019","article-title":"Early ascertainment of breast cancer diagnoses comparing self-reported questionnaires and electronic health record data warehouse: the WISDOM study.","volume":"7","author":"Leggat-Barr","year":"2023","journal-title":"JCO Clin Cancer Inform"},{"issue":"1","key":"joi250118r21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2024.21972","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human participants.","volume":"333","author":"World Medical Association","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"joi250118r22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10549-019-05167-2","article-title":"Validation of the breast cancer surveillance consortium model of breast cancer risk.","volume":"175","author":"Tice","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"joi250118r23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw290","article-title":"Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial.","volume":"109","author":"Shieh","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"joi250118r24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13073-025-01524-7","article-title":"Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial.","volume":"17","author":"Fergus","year":"2025","journal-title":"Genome Med"},{"issue":"1","key":"joi250118r25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41523-021-00306-9","article-title":"Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry.","volume":"7","author":"Huilgol","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"joi250118r26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41523-021-00288-8","article-title":"Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial.","volume":"7","author":"Keane","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"joi250118r27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41523-024-00681-z","article-title":"Validation study of risk-reduction activities after personalized breast cancer education tool in the WISDOM study.","volume":"10","author":"Wang","year":"2024","journal-title":"NPJ Breast Cancer"},{"issue":"2","key":"joi250118r29","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.0006-341X.2000.00554.x","article-title":"Nonparametric analysis of recurrent events and death.","volume":"56","author":"Ghosh","year":"2000","journal-title":"Biometrics"},{"issue":"10","key":"joi250118r30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.7326\/M16-0476","article-title":"Tailoring breast cancer screening intervals by breast density and risk for women aged 50 years or older: collaborative modeling of screening outcomes.","volume":"165","author":"Trentham-Dietz","year":"2016","journal-title":"Ann Intern Med"},{"issue":"8","key":"joi250118r31","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/jnci\/djaa218","article-title":"Trade-offs between harms and benefits of different breast cancer screening intervals among low-risk women.","volume":"113","author":"van Ravesteyn","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"joi250118r32","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors.","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"issue":"9","key":"joi250118r33","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jacr.2023.04.002","article-title":"Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR.","volume":"20","author":"Monticciolo","year":"2023","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"joi250118r35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000540680","article-title":"Receiving a pathogenic variant in a population breast cancer screening trial: a mixed method study.","volume":"27","author":"Riddle","year":"2024","journal-title":"Public Health Genomics"},{"key":"joi250118r36","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.7323","article-title":"Germline pathogenic variants among women without a history of breast cancer: a secondary analysis of the WISDOM randomized clinical trial.","author":"Fergus","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"1","key":"joi250118r37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10549-024-07329-3","article-title":"Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations.","volume":"207","author":"Elson","year":"2024","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"joi250118r38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1245\/s10434-023-14394-3","article-title":"Universal germline-genetic testing for breast cancer: implementation in a rural practice and impact on shared decision-making.","volume":"31","author":"Shelton","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"joi250118r39","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.31427","article-title":"Universal genetic testing for newly diagnosed invasive breast cancer.","volume":"7","author":"Rezoug","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"joi250118r40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/jmg-2024-110390","article-title":"The NHS England Jewish BRCA Testing Programme: overview after first year of implementation (2023-2024).","volume":"62","author":"Torr","year":"2025","journal-title":"J Med Genet"},{"issue":"8","key":"joi250118r41","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s11606-019-05026-2","article-title":"The impact of breast density notification laws on supplemental breast imaging and breast biopsy.","volume":"34","author":"Saulsberry","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"1","key":"joi250118r42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-021-06203-w","article-title":"The impact of mandatory mammographic breast density notification on supplemental screening practice in the United States: a systematic review.","volume":"187","author":"Huang","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"5S","key":"joi250118r43","doi-asserted-by":"publisher","first-page":"S405","DOI":"10.1016\/j.jacr.2025.02.023","article-title":"ACR Appropriateness Criteria Supplemental Breast Cancer Screening Based on Breast Density: 2024 update.","volume":"22","author":"Paulis","year":"2025","journal-title":"J Am Coll Radiol"},{"issue":"10","key":"joi250118r44","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju255","article-title":"Prevalence of mammographically dense breasts in the United States.","volume":"106","author":"Sprague","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"joi250118r45","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10198-021-01338-5","article-title":"Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies.","volume":"22","author":"M\u00fchlberger","year":"2021","journal-title":"Eur J Health Econ"},{"issue":"1","key":"joi250118r47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12885-025-13848-z","article-title":"Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study.","volume":"25","author":"Roux","year":"2025","journal-title":"BMC Cancer"},{"issue":"6","key":"joi250118r48","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3390\/life14060777","article-title":"Screening for breast cancer: a comparative review of guidelines.","volume":"14","author":"Katsika","year":"2024","journal-title":"Life (Basel)"},{"key":"joi250118r49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmqr.2024.100476","article-title":"\u201cMammograms are kind of my pacifier\u201d: the cultural context of women\u2019s preference for annual mammograms in a risk-based screening cohort.","volume":"6","author":"Leggat-Barr","year":"2024","journal-title":"SSM Qual Res Health"},{"issue":"6","key":"joi250118r51","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/aje\/kwad035","article-title":"Design and implementation of the All of Us research program COVID-19 Participant Experience (COPE) survey.","volume":"192","author":"Schulkey","year":"2023","journal-title":"Am J Epidemiol"},{"issue":"3","key":"joi250118r52","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10549-023-07124-6","article-title":"Screening mammographic performance by race and age in the National Mammography Database: 29,479,665 screening mammograms from 13,181,241 women.","volume":"203","author":"Lee","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"joi250118r28","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-68560-1","volume-title":"Survival and Event History Analysis: A Process Point of View","author":"Aalen","year":"2008"},{"key":"joi250118r34","author":"Naeim","year":"2018"},{"key":"joi250118r46","author":"Badal","year":"2025"},{"key":"joi250118r14","unstructured":"Sekar? K. Centers for Disease Control and Prevention (CDC) funding overview. Congress.gov. July 16, 2024. Accessed October 7, 2025. https:\/\/www.congress.gov\/crs-product\/R47207"},{"key":"joi250118r19","doi-asserted-by":"crossref","unstructured":"Fiscalini? A, Blum? K, Fergus? K, . WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design.? 2025. doi:10.21203\/rs.3.rs-7665355\/v1","DOI":"10.21203\/rs.3.rs-7665355\/v2"},{"key":"joi250118r50","unstructured":"National Institutes of Health. Science meets reality: recruitment and retention of women in clinical studies, and the critical role of relevance: January 6-9, 2003. 2003. Accessed November 22, 2025. https:\/\/repository.library.georgetown.edu\/handle\/10822\/547438"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2842903\/jama_esserman_2025_oi_250118_1774294710.34043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:00:23Z","timestamp":1774537223000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2842903"}},"subtitle":["The WISDOM Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,3,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2025.24784","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,3]]}}}